Annual Short Term Debt
$8.32 B
+$2.01 B+31.83%
December 31, 2024
Summary
- As of February 7, 2025, NVS annual short term debt is $8.32 billion, with the most recent change of +$2.01 billion (+31.83%) on December 31, 2024.
- During the last 3 years, NVS annual short term debt has risen by +$1.82 billion (+28.02%).
- NVS annual short term debt is now -15.72% below its all-time high of $9.88 billion, reached on December 31, 2020.
Performance
NVS Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$8.32 B
+$1.51 B+22.18%
December 31, 2024
Summary
- As of February 7, 2025, NVS quarterly short term debt is $8.32 billion, with the most recent change of +$1.51 billion (+22.18%) on December 31, 2024.
- Over the past year, NVS quarterly short term debt has increased by +$2.01 billion (+31.83%).
- NVS quarterly short term debt is now -49.80% below its all-time high of $16.58 billion, reached on March 31, 2011.
Performance
NVS Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
NVS Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.8% | +31.8% |
| 3 y3 years | +28.0% | +46.9% |
| 5 y5 years | +17.4% | +46.9% |
NVS Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +35.9% | -2.8% | +46.9% |
| 5 y | 5-year | -15.7% | +35.9% | -25.7% | +46.9% |
| alltime | all time | -15.7% | +265.1% | -49.8% | +265.1% |
Novartis AG Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $8.32 B(+31.8%) | $8.32 B(+22.2%) |
| Sep 2024 | - | $6.81 B(-12.2%) |
| Jun 2024 | - | $7.76 B(-9.3%) |
| Mar 2024 | - | $8.56 B(+35.6%) |
| Dec 2023 | $6.31 B(+3.1%) | $6.31 B(+11.4%) |
| Sep 2023 | - | $5.67 B(-33.6%) |
| Jun 2023 | - | $8.54 B(+18.2%) |
| Mar 2023 | - | $7.22 B(+17.8%) |
| Dec 2022 | $6.13 B(-5.8%) | $6.13 B(-16.1%) |
| Sep 2022 | - | $7.30 B(0.0%) |
| Jun 2022 | - | $7.30 B(+4.8%) |
| Mar 2022 | - | $6.97 B(+7.2%) |
| Dec 2021 | $6.50 B(-34.2%) | $6.50 B(-32.4%) |
| Sep 2021 | - | $9.61 B(+2.8%) |
| Jun 2021 | - | $9.35 B(-10.4%) |
| Mar 2021 | - | $10.44 B(+5.7%) |
| Dec 2020 | $9.88 B(+39.3%) | $9.88 B(-1.2%) |
| Sep 2020 | - | $9.99 B(+9.4%) |
| Jun 2020 | - | $9.13 B(-18.5%) |
| Mar 2020 | - | $11.21 B(+58.0%) |
| Dec 2019 | $7.09 B(-26.3%) | $7.09 B(-14.4%) |
| Sep 2019 | - | $8.28 B(+1.6%) |
| Jun 2019 | - | $8.15 B(+5.8%) |
| Mar 2019 | - | $7.70 B(-19.9%) |
| Dec 2018 | $9.62 B(+85.0%) | $9.62 B(+4.8%) |
| Sep 2018 | - | $9.18 B(-4.4%) |
| Jun 2018 | - | $9.60 B(-12.1%) |
| Mar 2018 | - | $10.91 B(+109.8%) |
| Dec 2017 | $5.20 B(-10.2%) | $5.20 B(-25.7%) |
| Sep 2017 | - | $7.00 B(-7.5%) |
| Jun 2017 | - | $7.56 B(-9.2%) |
| Mar 2017 | - | $8.32 B(+43.8%) |
| Dec 2016 | $5.79 B(+3.9%) | $5.79 B(-30.3%) |
| Sep 2016 | - | $8.31 B(-17.7%) |
| Jun 2016 | - | $10.09 B(-13.2%) |
| Mar 2016 | - | $11.63 B(+108.6%) |
| Dec 2015 | $5.57 B(-15.0%) | $5.57 B(-40.0%) |
| Sep 2015 | - | $9.29 B(-6.9%) |
| Jun 2015 | - | $9.97 B(-3.0%) |
| Mar 2015 | - | $10.28 B(+56.7%) |
| Dec 2014 | $6.56 B(-1.7%) | $6.56 B(-5.4%) |
| Sep 2014 | - | $6.94 B(-8.2%) |
| Jun 2014 | - | $7.56 B(+25.7%) |
| Mar 2014 | - | $6.01 B(-10.0%) |
| Dec 2013 | $6.67 B(+12.2%) | $6.67 B(-12.8%) |
| Sep 2013 | - | $7.66 B(+5.5%) |
| Jun 2013 | - | $7.26 B(-22.3%) |
| Mar 2013 | - | $9.33 B(+57.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $5.95 B(-6.7%) | $5.95 B(+18.5%) |
| Sep 2012 | - | $5.02 B(-43.5%) |
| Jun 2012 | - | $8.88 B(-17.0%) |
| Mar 2012 | - | $10.70 B(+67.8%) |
| Dec 2011 | $6.37 B(-25.7%) | $6.37 B(-37.2%) |
| Sep 2011 | - | $10.15 B(-25.2%) |
| Jun 2011 | - | $13.58 B(-18.1%) |
| Mar 2011 | - | $16.58 B(+93.2%) |
| Dec 2010 | $8.58 B(+64.0%) | $8.58 B(-32.0%) |
| Sep 2010 | - | $12.63 B(+133.6%) |
| Jun 2010 | - | $5.41 B(+20.6%) |
| Mar 2010 | - | $4.48 B(-14.3%) |
| Dec 2009 | $5.23 B(+7.7%) | $5.23 B(-7.5%) |
| Sep 2009 | - | $5.66 B(+21.1%) |
| Jun 2009 | - | $4.67 B(+4.4%) |
| Mar 2009 | - | $4.47 B(-7.9%) |
| Dec 2008 | $4.86 B(-1.2%) | $4.86 B(-44.4%) |
| Sep 2008 | - | $8.74 B(+2.1%) |
| Jun 2008 | - | $8.56 B(+49.3%) |
| Mar 2008 | - | $5.73 B(+16.6%) |
| Dec 2007 | $4.92 B(-25.1%) | $4.92 B(-25.2%) |
| Sep 2007 | - | $6.58 B(-3.6%) |
| Jun 2007 | - | $6.82 B(+1.9%) |
| Mar 2007 | - | $6.69 B(+2.0%) |
| Dec 2006 | $6.56 B(-4.8%) | $6.56 B(-9.6%) |
| Sep 2006 | - | $7.26 B(-7.1%) |
| Jun 2006 | - | $7.81 B(+15.7%) |
| Mar 2006 | - | $6.75 B(-2.0%) |
| Dec 2005 | $6.89 B(+80.3%) | $6.89 B(+54.2%) |
| Sep 2005 | - | $4.47 B(-14.1%) |
| Jun 2005 | - | $5.20 B(+50.5%) |
| Mar 2005 | - | $3.46 B(-9.6%) |
| Dec 2004 | $3.82 B(+67.6%) | $3.82 B(+46.1%) |
| Sep 2004 | - | $2.62 B(-9.3%) |
| Jun 2004 | - | $2.88 B(-15.2%) |
| Mar 2004 | - | $3.40 B(+49.1%) |
| Dec 2003 | $2.28 B(-9.2%) | $2.28 B(-11.7%) |
| Sep 2003 | - | $2.58 B(-34.6%) |
| Jun 2003 | - | $3.95 B(+32.4%) |
| Mar 2003 | - | $2.98 B(+18.8%) |
| Dec 2002 | $2.51 B(-18.0%) | $2.51 B(-24.6%) |
| Sep 2002 | - | $3.33 B(-3.6%) |
| Jun 2002 | - | $3.45 B(+12.8%) |
| Dec 2001 | $3.06 B(+30.8%) | $3.06 B(+3.9%) |
| Jun 2001 | - | $2.95 B(+25.9%) |
| Dec 2000 | $2.34 B(-50.1%) | $2.34 B(-36.3%) |
| Jun 2000 | - | $3.67 B |
| Dec 1999 | $4.70 B(+6.4%) | - |
| Dec 1998 | $4.41 B | - |
FAQ
- What is Novartis AG annual short term debt?
- What is the all time high annual short term debt for Novartis AG?
- What is Novartis AG annual short term debt year-on-year change?
- What is Novartis AG quarterly short term debt?
- What is the all time high quarterly short term debt for Novartis AG?
- What is Novartis AG quarterly short term debt year-on-year change?
What is Novartis AG annual short term debt?
The current annual short term debt of NVS is $8.32 B
What is the all time high annual short term debt for Novartis AG?
Novartis AG all-time high annual short term debt is $9.88 B
What is Novartis AG annual short term debt year-on-year change?
Over the past year, NVS annual short term debt has changed by +$2.01 B (+31.83%)
What is Novartis AG quarterly short term debt?
The current quarterly short term debt of NVS is $8.32 B
What is the all time high quarterly short term debt for Novartis AG?
Novartis AG all-time high quarterly short term debt is $16.58 B
What is Novartis AG quarterly short term debt year-on-year change?
Over the past year, NVS quarterly short term debt has changed by +$2.01 B (+31.83%)